focus -WSS

focus

author：focus 2025-09-30 00:48:13 - browse：97

John Thune raises one hand while speaking to the press at the Capitol 2024 — politics coverage from STAT — Sen. John Thune is one of a group of lawmakers that is working on 340B reform legislation. BRENDAN SMIALOWSKI/AFP via Getty Images

WASHINGTON — A bipartisan group of senators released a draft of legislation to resolve controversial disputes in the 340B drug discount program, according to documents obtained by STAT.

The drug discount program, which was designed to support providers that serve low-income patients, has been increasingly contentious as it’s grown in recent years. The draft legislation makes a number of changes to address some of the most controversial points, including its rules over so-called “contract pharmacies” and which subsidiaries can qualify for discounts.

The draft would also require more oversight, and it would give the Health Resources and Services Administration more money to do it with a new user fee program. Providers would pay HRSA up to 0.1% of the savings it receives from the program.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： BioMarin wins approval for gene therapy to treat hemophilia A
Next article： FDA approves Eli Lilly ulcerative colitis treatment Omvoh

hotspot

WSS

STAT Wunderkinds: Ruey Hu's digital tools for parsing research

FDA approves Eli Lilly ulcerative colitis treatment Omvoh

Weight loss drug Wegovy cuts risk of heart attacks in milestone trial

Why medical students are struggling with mental health

Morphosys mixed study results for blood cancer drug

Readout Newsletter: What is Casgevy? Does Wegovy hurt muscle?

focus

focus

focus

Heart attack and stroke risk calculators need revising

Readout Newsletter: What is Casgevy? Does Wegovy hurt muscle?

New air purifier tech could be key to improving indoor air quality

NYU radiologists take on the challenge of expensive MRI machines

Hepatitis C has a cure — but many Americans still lack access to it

Physician subsidies by hospitals soar in wake of No Surprises Act

Jerome Adams on the need for new antivirals for Covid

Chimpanzees, like humans and whales, get menopause: Study

In age of alternative facts, a scholarly course on calling out crap

The FDA weighs the risks of candy

focus

FDA's Woodcock to retire early next year

Wegovy, Zepbound and weight loss drugs that preserve muscle

CRISPR pioneers react to Casgevy, first gene

Does good food count as health care? Study aims to find out

Readout Newsletter: Bayer study halts, Carmot to IPO, and more

CRISPR pioneers react to Casgevy, first gene

hotspot

hotspot

focus

hotspot